During the past decade, University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy" are "Breast Neoplasms" (1 trials) and "Kidney Neoplasms" (1 trials). Many other conditions were trialed in "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy" in a lesser frequency.

Most popular intervention types in "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Afatinib" (1 trials), "Axitinib (AG-013736)" (1 trials), "Letrozole" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".